Cryopyrin-associated periodic syndrome classification: Difference between revisions
(Created page with "__NOTOC__ {{Cryopyrin-associated periodic syndrome}} {{CMG}}; {{AE}} {{Sahar}} ==Overview== The cryopyrin-associated periodic syndrome may be classified according to clinica...") |
|||
Line 7: | Line 7: | ||
The cryopyrin-associated periodic syndrome may be classified according to clinical phenotype into three subtypes: familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID) | The cryopyrin-associated periodic syndrome may be classified according to clinical phenotype into three subtypes: familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID) | ||
==Classification== | ==Classification== | ||
*The cryopyrin-associated periodic syndrome may be classified according to | *The cryopyrin-associated periodic syndrome may be classified according to clinical phenotype into three subtypes:<ref name="AksentijevichNowak2002">{{cite journal|last1=Aksentijevich|first1=Ivona|last2=Nowak|first2=Miroslawa|last3=Mallah|first3=Mustapha|last4=Chae|first4=Jae Jin|last5=Watford|first5=Wendy T.|last6=Hofmann|first6=Sigrun R.|last7=Stein|first7=Leonard|last8=Russo|first8=Ricardo|last9=Goldsmith|first9=Donald|last10=Dent|first10=Peter|last11=Rosenberg|first11=Helene F.|last12=Austin|first12=Frances|last13=Remmers|first13=Elaine F.|last14=Balow|first14=James E.|last15=Rosenzweig|first15=Sergio|last16=Komarow|first16=Hirsh|last17=Shoham|first17=Nitza G.|last18=Wood|first18=Geryl|last19=Jones|first19=Janet|last20=Mangra|first20=Nadira|last21=Carrero|first21=Hector|last22=Adams|first22=Barbara S.|last23=Moore|first23=Terry L.|last24=Schikler|first24=Kenneth|last25=Hoffman|first25=Hal|last26=Lovell|first26=Daniel J.|last27=Lipnick|first27=Robert|last28=Barron|first28=Karyl|last29=O'Shea|first29=John J.|last30=Kastner|first30=Daniel L.|last31=Goldbach-Mansky|first31=Raphaela|title=De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases|journal=Arthritis & Rheumatism|volume=46|issue=12|year=2002|pages=3340–3348|issn=0004-3591|doi=10.1002/art.10688}}</ref> | ||
**Familial cold autoinflammatory syndrome (FCAS) | **Familial cold autoinflammatory syndrome (FCAS) | ||
**Muckle-Wells syndrome (MWS) | **Muckle-Wells syndrome (MWS) | ||
**Neonatal-onset multisystem inflammatory disease (NOMID) | **Neonatal-onset multisystem inflammatory disease (NOMID) | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 14:17, 2 July 2019
Cryopyrin-associated periodic syndrome Microchapters |
Differentiating Cryopyrin-associated periodic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryopyrin-associated periodic syndrome classification On the Web |
American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome classification |
FDA on Cryopyrin-associated periodic syndrome classification |
CDC on Cryopyrin-associated periodic syndrome classification |
Cryopyrin-associated periodic syndrome classification in the news |
Blogs on Cryopyrin-associated periodic syndrome classification |
Risk calculators and risk factors for Cryopyrin-associated periodic syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
The cryopyrin-associated periodic syndrome may be classified according to clinical phenotype into three subtypes: familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID)
Classification
- The cryopyrin-associated periodic syndrome may be classified according to clinical phenotype into three subtypes:[1]
- Familial cold autoinflammatory syndrome (FCAS)
- Muckle-Wells syndrome (MWS)
- Neonatal-onset multisystem inflammatory disease (NOMID)
References
- ↑ Aksentijevich, Ivona; Nowak, Miroslawa; Mallah, Mustapha; Chae, Jae Jin; Watford, Wendy T.; Hofmann, Sigrun R.; Stein, Leonard; Russo, Ricardo; Goldsmith, Donald; Dent, Peter; Rosenberg, Helene F.; Austin, Frances; Remmers, Elaine F.; Balow, James E.; Rosenzweig, Sergio; Komarow, Hirsh; Shoham, Nitza G.; Wood, Geryl; Jones, Janet; Mangra, Nadira; Carrero, Hector; Adams, Barbara S.; Moore, Terry L.; Schikler, Kenneth; Hoffman, Hal; Lovell, Daniel J.; Lipnick, Robert; Barron, Karyl; O'Shea, John J.; Kastner, Daniel L.; Goldbach-Mansky, Raphaela (2002). "De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases". Arthritis & Rheumatism. 46 (12): 3340–3348. doi:10.1002/art.10688. ISSN 0004-3591.